Mainstream

OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition

OraSure signals Q3 revenue outlook of $27M–$30M as it launches new proteomics product and completes manufacturing transition

Post ContentosurRead More

You might also be interested in reading Xtrackers USD High Yield BB-B ex Financials ETF declares monthly distribution of $0.2950.

August 6, 2025
In Mainstream